RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CStone Pharmaceuticals Stock

CStone Pharmaceuticals Liabilities 2024

CStone Pharmaceuticals Liabilities

1.21 B CNY

Ticker

2616.HK

ISIN

KYG2588M1006

WKN

A2PEFW

In 2024, CStone Pharmaceuticals's total liabilities amounted to 1.21 B CNY, a 1.35% difference from the 1.19 B CNY total liabilities in the previous year.

CStone Pharmaceuticals Aktienanalyse

What does CStone Pharmaceuticals do?

CStone Pharmaceuticals is a biopharmaceutical company founded in January 2016 by a team of experienced industry leaders. The company is headquartered in Suzhou, China, and focuses on the discovery, development, and commercialization of innovative therapeutics in the fields of oncology, immunology, and metabolic disorders. CStone aims to improve healthcare worldwide and extend and enhance the lives of patients through the development of cutting-edge medical solutions. CStone Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing CStone Pharmaceuticals's Liabilities

CStone Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating CStone Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing CStone Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

CStone Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in CStone Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about CStone Pharmaceuticals stock

What is the level of liabilities of CStone Pharmaceuticals this year?

CStone Pharmaceuticals has a debt balance of 1.21 B CNY this year.

What were the liabilities of CStone Pharmaceuticals compared to the previous year?

The liabilities of CStone Pharmaceuticals have increased by 1.35% increased compared to the previous year.

What are the consequences of high debt for investors of CStone Pharmaceuticals?

High liabilities can pose a risk for investors of CStone Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in CStone Pharmaceuticals?

Low liabilities mean that CStone Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of CStone Pharmaceuticals affect the company?

An increase in liabilities of CStone Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of CStone Pharmaceuticals affect the company?

A decrease in the liabilities of CStone Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of CStone Pharmaceuticals?

Some factors that can influence the liabilities of CStone Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of CStone Pharmaceuticals so important for investors?

The liabilities of CStone Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can CStone Pharmaceuticals take to modify the liabilities?

To change its liabilities, CStone Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does CStone Pharmaceuticals pay?

Over the past 12 months, CStone Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CStone Pharmaceuticals is expected to pay a dividend of 0 CNY.

What is the dividend yield of CStone Pharmaceuticals?

The current dividend yield of CStone Pharmaceuticals is .

When does CStone Pharmaceuticals pay dividends?

CStone Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CStone Pharmaceuticals?

CStone Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of CStone Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is CStone Pharmaceuticals located?

CStone Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von CStone Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CStone Pharmaceuticals from 10/22/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/22/2024.

When did CStone Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/22/2024.

What was the dividend of CStone Pharmaceuticals in the year 2023?

In the year 2023, CStone Pharmaceuticals distributed 0 CNY as dividends.

In which currency does CStone Pharmaceuticals pay out the dividend?

The dividends of CStone Pharmaceuticals are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CStone Pharmaceuticals

Our stock analysis for CStone Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CStone Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.